1-8 of 8
Erika Kettner, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Term Follow up of the AML97-Study for Patients with AML Older Than 60 Years: A Study of the East German Hematology and Oncology Study Group (OSHO)

Christoph Kahl, MD, Rainer Krahl, PhD, Haifa Kathrin Al-Ali, MD, Herbert G. Sayer, MD PhD, Antje Schulze, MD, Michael Herold, MDPhD, Mathias Hänel, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Lutz Uharek, MD, Georg Maschmeyer, MD, Detlev Hähling, MD, Christian Junghanss, MD, Norma Peter, Dietrich Kämpfe, MD, Erika Kettner, MD, Thomas Heinicke, MD, Thomas Fischer, MD, Ute Kreibich, MD, Hans-Heinrich Wolf, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2014) 124 (21): 3664.
https://doi.org/10.1182/blood.V124.21.3664.3664
Published: 2014
Journal Articles

Immunochemotherapy (R-MCP) Is Not Superior to Chemotherapy (MCP) Alone in Advanced Mantle Cell Lymphoma - 42 Months Follow Up Results of the OSHO 39 Study.

Michael Herold, MD, Antje Haas, MD, Stephanie Srock, MD, Sabine Neser, MD, Kathrin H. Al Ali, MD, Andreas Neubauer, MD, Gottfried Doelken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Martin Mohren, MD, Thomas H. Ittel, MD, Erika Kettner, MD
Journal: Blood
Blood (2007) 110 (11): 4474.
https://doi.org/10.1182/blood.V110.11.4474.4474
Published: 2007
Journal Articles

Increased Leukaemia Free Survival (LFS) in Patients with Cytogenetic High Risk AML after Related or Unrelated Hematopoietic Cell Transplantation (HCT) Compared to Chemotherapy in the OSHO 96 and 2002 Studies.

Dietger Niederwieser, MD, Cornelia Becker, MD, Rainer Krahl, Ph.D., Haifa-Kathrin Al-Ali, MD, Simone Heyn, MD, Michael Cross, Ph.D., Thoralf Lange, MD, Anke Gerhardt, MD, Antje Schulze, MD, Detleff Haehling, MD, Manfred Schulze, MD, Matthias Freund, MD, Erika Kettner, MD, Gottfried Dölken, MD, Michael Assmann, MD, Hans-Heinrich Wolf, MD, Ernst Zschuppe, MD, Norma Peter, MD, Astrid Franke, MD, Ulrich Wedding, MD, Lutz Uharek, MD, Ute Kreibich, MD, Norbert Grobe, MD, Thomas Ittel, MD, Axel Florschuetz, MD, Bernd Opitz, MD, Karin Senftleben, MD, Veronika Schirmer, MD, Friedrich Fiedler, MD, Renate Huhn, MD, Werner Helbig, MD
Journal: Blood
Blood (2006) 108 (11): 264.
https://doi.org/10.1182/blood.V108.11.264.264
Published: 2006
Journal Articles

Addition of Rituximab to First-Line MCP (Mitoxantrone, Chlorambucil, Prednisolone) Chemotherapy Prolongs Survival in Advanced Follicular Lymphoma - 4 Year Follow-Up Results of a Phase III Trial of the East German Study Group Hematology and Oncology (OSHO#39).

Michael Herold, MD, Antje Haas, MD, Stephanie Srock, MD, Sabine Neser, MD, Kathrin H. Al Ali, MD, Andreas Neubauer, MD, Gottfried Doelken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Astrid Franke, MD, Thomas H. Ittel, MD, Erika Kettner, MD
Journal: Blood
Blood (2006) 108 (11): 484.
https://doi.org/10.1182/blood.V108.11.484.484
Published: 2006
Journal Articles

Cytogenetics and De Novo/Secondary AML but Not Age Are the Main Determinants for CR Rate and Hematological Recovery in Acute Myeloid Leukemia (AML) Using Intermediate Doses of Cytarabine (AraC) Delivered at the Presumptive Saturating Infusion Rate.

Cornelia Becker, MD, Haifa Al Ali, MD, Rainer Krahl, PhD, Wolfram Poenisch, MD, Dirk Hasenclever, PhD, Luisa Mantovani, MD, Mathias Freund, MD, R. Subert, MD, Ute Hegenbart, MD, Ulrich Wedding, MD, Johannes Meran, MD, Michael Herold, MD, Norma Peter, MD, W. Knauf, MD, Erika Kettner, MD, T. Ittel, MD, Astrid Franke, MD, K. Dachselt, MD, H.H. Wolf, MD, Ute Kreibich, MD, Manfred Schulze, MD, Michael Assmann, MD, Norbert Grobe, MD, Renate Huhn, MD, Ernst Zschuppe, MD, Veronika Schirmer, MD, U. Haak, MD, C. Klinkenstein, MD, B. Opitz, MD, Rita Pasold, MD, F. Fiedler, MD, C. Winkelmann, MD, Werner Helbig, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2005) 106 (11): 1851.
https://doi.org/10.1182/blood.V106.11.1851.1851
Published: 2005
Journal Articles

Results of a Prospective Randomised Open Label Phase III Study Comparing Rituximab Plus Mitoxantrone, Chlorambucile, Prednisolone Chemotherapy (R-MCP) Versus MCP Alone in Untreated Advanced Indolent Non-Hodgkin’s Lymphoma (NHL) and Mantle-Cell-Lymphoma (MCL).

Michael Herold, MD, Rita Pasold, MD, Stefanie Srock, MD, Sabine Neser, MD, Dietger Niederwieser, MD, Andreas Neubauer, MD, Gottfried Dölken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Astrid Franke, MD, Thomas H. Ittel, MD, Erika Kettner, MD, Ursula Haak, MD, Ullrich Mey, MD, Christian Klinkenstein, MD, Michael Assmann, MD, Ullrich von Gruenhagen, MD, Klaus Dachselt, MD, Helga Schwenke, MD, Dorothee Bleyl, MD, Heiner Wolf, MD, Sabine Hahnfeld, MD, Franz-Adolph Hoffmann, MD, Volker Lakner, MD, Peter Richter, MD, Detlev Hähling, MD, H. H. Wolf, MD, Henning Eschenburg, MD, M.-R. Clemens, MD, Norbert Grobe, MD
Journal: Blood
Blood (2004) 104 (11): 584.
https://doi.org/10.1182/blood.V104.11.584.584
Published: 2004
Journal Articles

High Complete Remission Rate in Patients with Acute Myeloid Leukemia (AML) above the Age of 60 Years: A Report of the AML97#38 Study of the East German Hematology and Oncology Study Group.

Cornelia Becker, MD, Haifa Al Ali, MD, Rainer Krahl, PhD, Wolfram Poenisch, MD, Ulrich Wedding, MD, Ferdinand Fiedler, MD, Rita Pasold, MD, Matthias Freund, MD, Rita Subert, MD, Dietrich Kaempfe, MD, Johannes Meran, MD, Manfred Herold, MD, Norma Peter, MD, Wolfgang Knauf, MD, Erika Kettner, MD, Wolfgang Schultze, MD, Klaus Dachselt, MD, Hans Heinrich Wolf, MD, Ute Kreibich, MD, Manfred Schulze, MD, Thomas Ittel, MD, Michael Assmann, MD, Norbert Grobe, MD, Renate Huhn, MD, Juergen Steglich, MD, Veronika Schirmer, MD, Christian Klinkenstein, MD, Bernhard Opitz, MD, Cornelia Winkelmann, MD, Ursula Haak, MD, Werner Helbig, MD, Dietger Niederwieser, MD
Journal: Blood
Blood (2004) 104 (11): 880.
https://doi.org/10.1182/blood.V104.11.880.880
Published: 2004
Journal Articles

Cost Evaluation of Rituximab Plus MCP vs. MCP Alone in Advanced Stage Indolent Non-Hodgkin’s-Lymphoma Based on a Randomized Controlled Multicenter Trial.

Klaus Hieke, Rita Pasold, MD, Sabine Neser, MD, Dietger Niederwieser, MD, Andreas Neubauer, MD, Gottfried Doelken, MD, Ralph Naumann, MD, Thomas Fietz, MD, Mathias Freund, MD, Robert Rohrberg, MD, Klaus Hoeffken, MD, Astrid Franke, MD, Thomas-Hein Ittel, MD, Erika Kettner, MD, Ursula Haak, MD, Ullrich Mey, MD, Christian Klinkenstein, MD, M. Assmann, MD, Ullrich von Gruenhagen, MD, Klaus Dachselt, MD, Helga Schwenke, MD, Dorothee Bleyl, MD, Heiner Wolf, MD, Sabine Hahnfels, MD, Franz-Adolph Hoffmann, MD, Volker Lakner, MD, Peter Richter, MD, Detlev Haehling, MD, H.H. Wolf, MD, H. Eschenburg, MD, N. Grobe, MD, M.-R. Clemens, MD, Michael Herold, MD
Journal: Blood
Blood (2004) 104 (11): 87.
https://doi.org/10.1182/blood.V104.11.87.87
Published: 2004